Figure 3From: Bezafibrate improves insulin resistance evaluated using the glucose clamp technique in patients with type 2 diabetes mellitus: a small-scale clinical studyAreas under the plasma glucose and IRI curves from 0 to 180 min in the MTT at baseline and after 12 weeks of treatment with bezafibrate (n = 12). AUC0–180 min = area under the curve from 0 to 180 min; IRI = immunoreactive insulin; PG = plasma glucose. *p < 0.05 vs. baseline (paired t test).Back to article page